Clinical trial
Irinotecan in Treating Children With Refractory or Progressive Solid Tumors
NCT00016861 · Texas Children's Cancer Center, Other · Completed
Key facts
| NCT number | NCT00016861 |
|---|---|
| Title | Irinotecan in Treating Children With Refractory or Progressive Solid Tumors |
| Official title | Pediatric Phase I and Pharmacokinetic Study of Irinotecan |
| Lead sponsor | Texas Children's Cancer Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride |
| Start date | Sep 1, 1998 |
| Completion | Jan 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: